Valine and isoleucine requirement of 20- to 45-kilogram pigs.

Three experiments were conducted to determine the Val and Ile requirements in low-CP, corn-soybean meal (C-SBM) AA-supplemented diets for 20- to 45-kg pigs. All experiments were conducted for 26 to 27 d with purebred or crossbred barrows and gilts, which were blocked by initial BW. Treatments were replicated with 5 or 6 pens of 3 or 4 pigs per pen. At the beginning of Exp. 1 and the end of all experiments, blood samples were obtained from all pigs to determine plasma urea N (PUN) concentrations. All diets were C-SBM with 0.335% supplemental Lys to achieve 0.83% standardized ileal digestible (SID) Lys, which is the Lys requirement of these pigs. In Exp. 1, 0, 0.02, 0.04, 0.06, 0.08, or 0.10% L-Val was supplemented to achieve 0.51, 0.53, 0.55, 0.57, 0.59, or 0.61% dietary SID Val, and Thr, Trp, Met, and Ile were supplemented to maintain Thr:Lys, Trp:Lys, TSAA:Lys, and Ile:Lys ratios of 0.71, 0.20, 0.62, and 0.60, respectively. Also, supplemental Gly and Glu were added to all diets to achieve 1.66% Gly + Ser and 3.28% Glu, which is equal to the Gly + Ser and Glu content of a previously validated positive control diet that contained no supplemental AA. Treatment differences were considered significant at P < 0.10. Valine addition increased ADG, ADFI, and G:F in pigs fed 0.51 to 0.59% SID Val (linear, P < 0.08), but ADG and ADFI were decreased at 0.61% SID Val (quadratic, P ≤ 0.10). On the basis of ADG and G:F, the SID Val requirement is between 0.56 and 0.58% in a C-SBM diet supplemented with AA. In Exp. 2 and 3, 0, 0.02, 0.04, 0.06, or 0.08% L-Ile was supplemented to achieve 0.43, 0.45, 0.47, 0.49, or 0.51% dietary SID Ile, and Thr, Trp, Met, and Ile were supplemented to maintain Thr:Lys, Trp:Lys, TSAA:Lys, and Val:Lys ratios of 0.71, 0.20, 0.62, and 0.74, respectively. Also, supplemental Gly and Glu were added to achieve 1.66% Gly + Ser and 3.28% Glu as in Exp. 1. Data from Exp. 2 and 3 were combined and analyzed as 1 data set. Daily BW gain, ADFI, and G:F were not affected by Ile additions to the diet; however, ADFI was decreased among pigs fed the diet with 0.45% SID Ile (P < 0.10) compared with pigs fed the 0.43% SID Ile diet. Broken-line analysis requirements could not be estimated for the combined data from Exp. 2 or 3. The results of this research indicate that the SID Val requirement is between 0.56 to 0.58% (0.67 to 0.70 SID Val:Lys), and the Ile requirement is adequate at 0.43% SID Ile (0.52 SID Ile:Lys) for 20- to 45-kg pigs.

Technical note: Effect of determining baseline plasma urea nitrogen concentrations on subsequent posttreatment plasma urea nitrogen concentrations in 20- to 50-kilogram pigs.

Plasma urea N (PUN) has been used as an indicator of AA requirements and efficiency of AA utilization in swine. However, PUN concentrations vary among a population of pigs, even a population with a close range of BW and fed the same diet. Thus, pretreatment or baseline PUN concentrations are used as a covariate to reduce variation of posttreatment PUN. However, this procedure increases experimental costs and stress to the pigs. Data from 14 experiments (26 to 28 d in duration) conducted using PUN as a response variable were compiled into 1 data set. Each experiment had 4 to 6 treatments. The purpose of this technical report was to summarize the effect of determining pretreatment baseline PUN concentrations on subsequent posttreatment PUN concentrations in 20- to 50-kg pigs. In all experiments, pigs were fed corn- and soybean meal-based diets and low-CP diets with various AA additions; pigs were assigned to dietary treatments in a randomized complete block design with a minimum of 4 replicates of 3 to 5 pigs each. Before the start of each experiment, all pigs were fed a common diet for a minimum of 3 d. Blood samples were collected from each pig before allotment to dietary treatments (d 0) and at the end of each experiment. The baseline (d 0) PUN was analyzed as a covariate for posttreatment PUN. Data from each experiment were analyzed without and with baseline PUN in the statistical model. In all experiments combined, there were 768 possible treatment comparisons. The covariate baseline PUN was statistically significant (P < 0.10) in 9 of 14 experiments. However, only 8 treatment differences changed statistical significance as a result of analyzing the data with baseline PUN as a covariate. These 8 treatment differences were in 3 experiments. These results indicate that it is not always necessary to determine baseline PUN concentrations when feeding diets with large differences in AA content.

Maximizing the use of supplemental amino acids in corn-soybean meal diets for 20- to 45-kilogram pigs.

Four experiments were conducted to determine the Lys requirement, the maximum amount of supplemental Lys that does not decrease growth performance, and to determine the order of limiting AA beyond Lys, Thr, Trp, and Met in a corn-soybean meal diet for 20- to 45-kg pigs. All experiments were conducted for 27 to 28 d with purebred or crossbred barrows and gilts, which were blocked by initial BW. Treatments were replicated with 4 to 6 pens of 4 to 6 pigs per pen. In all experiments, pigs and feeders were weighed on d 0, 14, and 27 or 28. At the beginning and end of all experiments, blood samples were obtained from all pigs to determine plasma urea N (PUN) concentrations. In Exp. 1, 0.830, 0.872, 0.913, and 0.955% standardized ileal digestible (SID) Lys was fed, whereas 0.747, 0.788, 0.830, 0.872, and 0.913% SID Lys was fed in Exp. 2. Broken-line analysis requirement estimates could not be estimated from any response variable in Exp. 1, but in Exp. 2, using ADG and PUN, the estimated SID Lys requirement was 0.83%. In Exp. 3, 0, 0.118, 0.191, 0.264, and 0.335% supplemental Lys was added to achieve 0.83% SID Lys in all diets, and Thr, Trp, and Met were supplemented to maintain Thr:Lys, Trp:Lys, and TSAA:Lys of 0.65, 0.18, and 0.60, respectively. Based on ADG, ADFI, and G:F, up to 0.23% supplemental Lys can be added along with supplemental Thr, Trp, and Met without negatively affecting growth performance; PUN was linearly decreased (P < 0.001) by supplemental Lys. In Exp. 4, treatments were 1) positive control (PC) without supplemental AA, 2) negative control (NC) with 0.335% supplemental Lys + 0.140% l-Thr + 0.035% l-Trp + 0.117% dl-Met, 3) NC + 0.044% l-Val, 4) NC + 0.021% l-Ile, and 5) NC + 0.044% l-Val + 0.021% l-Ile. Individual addition of Val and Ile did not improve (P > 0.10) ADG or G:F compared with the NC. The combined addition of Val + Ile resulted in ADG that was intermediate between the PC and NC diets but not different from either diet (P > 0.10); G:F was not improved (P > 0.10) to that observed in pigs fed the PC diet. The PUN was not different (P > 0.10) among pigs fed diets with supplemental AA but less (P < 0.10) than pigs fed the PC. The results of this research indicate that the Lys requirement for 20- to 45-kg pigs is 0.83% SID Lys, up to 0.23% supplemental Lys (0.29% l-Lys·HCl or 0.45% l-Lys·SO(4)) can be added along with supplemental Thr, Trp, and Met without negatively affecting growth performance, and another AA besides Val and Ile may be limiting growth performance in a corn-soybean meal diet with 0.335% supplemental Lys.

Additivity of effects from dietary copper and zinc on growth performance and fecal microbiota of pigs after weaning.

Four experiments were conducted to determine the interactive effects of pharmacological amounts of Zn from ZnO and Cu from organic (Cu-AA complex; Cu-AA) or inorganic (CuSO(4)) sources on growth performance of weanling pigs. The Cu was fed for 4 (Exp. 1) or 6 (Exp. 2, 3, and 4) wk after weaning, and Zn was fed for 4 (Exp. 1) or 2 (Exp. 2, 3, and 4) wk after weaning. Treatments were replicated with 7 pens of 5 or 6 pigs per pen (19.0 ± 1.4 d of age and 5.8 ± 0.4 kg of BW, Exp. 1), 12 pens of 21 pigs per pen (about 21 d of age and 5.3 kg of BW, Exp. 2), 5 pens of 4 pigs per pen (20.3 ± 0.5 d of age and 7.0 ± 0.5 kg of BW, Exp. 3), and 16 pens of 21 pigs per pen (about 21 d of age and 5.7 kg of BW, Exp. 4). In Exp. 1 and 2, Cu-AA (0 vs. 100 mg/kg of Cu) and ZnO (0 vs. 3,000 mg/kg of Zn) were used in a 2 × 2 factorial arrangement. Only Exp. 1 used in-feed antibiotic (165 mg of oxytetracycline and 116 mg of neomycin per kilogram feed), and Exp. 2 was conducted at a commercial farm. In Exp. 3, sources of Cu (none; CuSO(4) at 250 mg/kg of Cu; and Cu-AA at 100 mg/kg of Cu) and ZnO (0 vs. 3,000 mg/kg of Zn) were used in a 3 × 2 factorial arrangement. In Exp. 4, treatments were no additional Cu, CuSO(4) at 315 mg/kg of Cu, or Cu-AA at 100 mg/kg of Cu to a diet supplemented with 3,000 mg/kg of Zn from ZnO and in-feed antibiotic (55 mg of carbadox per kilogram of feed). In Exp. 1 and 2, both Zn and Cu-AA improved (P < 0.001 to P = 0.03) ADG and ADFI. No interactions were observed, except in wk 1 of Exp. 2, where Zn increased the G:F only in the absence of Cu-AA (Cu-AA × Zn, P = 0.04). A naturally occurring colibacillosis diarrhea outbreak occurred during this experiment. The ZnO addition reduced (P < 0.001) the number of pigs removed and pig-days on antibiotic therapy. In Exp 3, ADFI in wk 2 was improved by Zn and Cu (P < 0.001 and P = 0.09, respectively) with no interactions. In wk 1, G:F was reduced by ZnO only in the absence of Cu (Cu × Zn, P = 0.03). Feeding Zn decreased fecal microbiota diversity in the presence of CuSO(4) but increased it in the presence of Cu-AA (Cu source × Zn, P = 0.06). In Exp. 4, Cu supplementation improved the overall ADG (P = 0.002) and G:F (P < 0.001). The CuSO(4) effect on G:F was greater (P < 0.001) than the Cu-AA effect. Our results indicate that pharmacological amounts of ZnO and Cu (Cu-AA or CuSO(4)) are additive in promoting growth of pigs after weaning.

Effect of incremental levels of L-lysine and determination of the limiting amino acids in low crude protein corn-soybean meal diets for broilers.

Research was conducted to determine the level of l-Lys that can be included in corn-soybean meal (C-SBM) diets for broilers before an amino acid (AA) beyond Met, Lys, Thr, or Gly becoming limiting and to determine the order of limiting AA in low CP C-SBM diets. All experiments were conducted with Ross 708 broilers (0 to 18 d of age) in brooder batteries. Treatments contained 7 or 8 replicates with 6 birds per replicate. In all experiments, a control C-SBM diet containing no l-Lys.HCl and a similar diet [positive control (PC) + Gly] with supplemental Gly to provide 2.32% total dietary Gly + Ser were fed. All diets were formulated to contain 1.26% total Lys. All diets with added l-Lys.HCl contained supplemental Gly to provide 2.32% total dietary Gly + Ser. In experiment 1, l-Lys.HCl was added to the diets at 0.02% increments from 0.15 to 0.27%. Compared with the PC + Gly diet, there were no negative effects (P > 0.10) of supplemental Lys on ADG, ADFI, or G:F. In experiment 2, l-Lys.HCl was added to the diets at 0.05% increments from 0.25 to 0.60%. Compared with the PC + Gly diet, ADG and G:F were decreased (P < 0.03) in broilers fed diets containing greater than 0.30% l-Lys.HCl but not (P > 0.10) in the 0.25% l-Lys.HCl diet. In experiment 3, l-Lys.HCl was added to the diets at 0.05% increments from 0.20 to 0.30%. Daily gain was decreased (P < 0.03) in broilers fed 0.30% l-Lys.HCl but not in those fed 0.20 or 0.25% l-Lys.HCl. In experiment 4, the order of limiting AA was determined in a C-SBM diet containing 0.45% L-Lys.HCl. In addition to the PC and PC + Gly diets, diets consisted of a negative control (NC) diet with 0.45% l-Lys.HCl, NC + 0.247% Ile, NC + 0.484% l-Arg.HCl, NC + 0.249% Val, and all possible 2- and l-way combinations of all 3 AA. Compared with the NC diet, addition of Arg and the combination of Arg and the other AA increased ADG and ADFI, indicating that Arg was the limiting AA in this diet. Experiment 5 was conducted in an identical manner to experiment 4 except the diets with the added AA contained the same ratio of corn to soybean meal that is present in a diet with 0.25% l-Lys.HCl. The results of experiment 5 suggest that Arg and Val are equaling limiting in a diet with 0.25% l-Lys.HCl. In summary, 0.25% l-Lys.HCl can be added to C-SBM diets supplemented with Met, Thr, and Gly with no negative effects on growth performance, and Arg and Val are equaling limiting (after Met, Thr, Lys, and Gly) in diets containing 0.25% l-Lys.HCl.

Naris occlusion alters transductory protein immunoreactivity in olfactory epithelium.

We have recently shown that unilateral naris occlusion (UNO) causes an increase in olfactory marker protein (OMP) immunoreactivity (IR) in mouse olfactory sensory neurons (OSN) from the occluded side of the nasal cavity and a decrease in OMP-IR on the non-occluded side, relative to controls. Given OMP's demonstrated role in olfactory modulation, these OMP-IR changes have been interpreted as a compensatory response by OSNs to odor deprivation on the occluded side and to supernormal exposure to odor on the non-occluded side of the nasal cavity. In the current study, we examined the developmental timing and the regional distribution of this process throughout the nasal cavity using immunocytochemistry. Results demonstrate that OMP-IR diverges in OSNs from the occluded side relative to the non-occluded side of the nasal cavity within eleven days after UNO, with statistically significant differences measurable after 17 days (n=16). We also measured relative levels of the Type 4 phosphodiesterase (PDE4A), another potential olfactory modulator, in nasal cavity tissue from UNO (n=8) and untreated mice (n=9) using western blots and immunocytochemistry. Like OMP, PDE4A-IR increased on the occluded side of the nasal cavity after UNO. Finally, we used immunocytochemistry to assess relative levels of olfactory-specific adenylyl cyclase (ACIII, n=4) and G-protein (Golf, n=2) in OSNs from the occluded and non-occluded sides of the nasal cavity of UNO mice. Following UNO, ACIII but not Golf -IR levels diverged comparing the occluded to the non-occluded sides of the nasal cavity. Taken together, our findings provide support for the previously unknown phenomenon of compensatory responses by OSNs to odor environment.

'Clearing' cervical spine injuries in polytrauma patients: is it really safe to remove the collar?

Polytrauma patients are at increased risk for occult cervical spine injuries. Those unable to provide clinical clues to injury either remain in hard collars until they are able to cooperate with the physical examination or are deemed "clear of cervical injury" if the emergency room screening radiographs are without obvious bony abnormality. Cervical immobilization for a lengthy period of time is not without morbidity. Missed ligamentous injuries can lead to cervical instability, which in turn can result in permanent neurologic sequelae. This article reviews the current methodologies to "clear the cervical spine" and highlights the inadequacies.

Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome.

Bilateral injection of naloxone (3.0-30.0 nmol) into the substantia nigra of morphine-dependent rats produced a withdrawal syndrome consisting of wet-dog shakes, teeth chattering, irritability to touch, diarrhea and hypothermia. Intense wet-dog shakes and grooming were observed after intranigral injection of the mu selective antagonist D-Phe-Cys-Try-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP, 3.0-30.0 nmol) in morphine-dependent animals. Body temperature after 30.0 nmol CTOP was significantly increased. A significant positive correlation between body temperature and wet-dog shakes was observed in morphine-dependent animals that received CTOP. Intranigral injection of beta-funaltrexamine (beta-FNA, 10.0 nmol), an irreversible mu antagonist, produced no signs of withdrawal in morphine-dependent animals. However, intranigral injection of beta-FNA (1.0-3.0 nmol) suppressed the antinociceptive effect of the mu-selective agonist, D-Ala2,N-Me-Phe4,Gly5-ol-enkephalin (DAGO, 1.0 nmol). The withdrawal syndrome produced by CTOP (10.0 nmol) was not suppressed by the administration of U50,488H (10.0 nmol), a kappa agonist, suggesting that the absence of an effect of beta-FNA was not due to its kappa agonist activity. Neither the delta-selective antagonist, naltrindole (NTI, 10.0 nmol) nor the kappa-selective antagonist, nor-binaltorphimine (nor-BNI, 10.0 nmol) produced withdrawal. Only wet-dog shakes were observed when CTOP, NTI and nor-BNI (5 nmol each) were administered together into the nigra. These studies suggest an involvement of mu receptors in the nigra in the wet-dog shakes and thermoregulatory dysfunction that occur during withdrawal of morphine. However, the subtypes of opioid receptors in the nigra, that mediate the other signs of morphine withdrawal remain obscure.